KRAIG BIOCRAFT LABORATORIES, INC.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $401.6K | $97.3K | $31.9K | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $148.1K | $258.9K | $397.1K | $432.0K | $439.5K | $489.4K | $465.3K | $250.6K |
| SG&A Expense | $515.9K | $1.2M | $1.7M | $920.9K | $896.1K | $1.3M | $379.3K | $786.9K |
| Operating Income | $-959.9K | $-2.2M | $-2.9M | $-2.1M | $-1.8M | $-2.2M | $-1.6M | $-1.3M |
| Operating Margin | -239.0% | -2,215.4% | -9,246.0% | — | — | — | — | — |
| Interest Expense | $229.0K | $177.1K | $139.4K | $101.5K | $69.3K | $65.6K | $45.7K | $0 |
| Pretax Income | $-1.2M | $-2.3M | $-3.1M | $-2.1M | $-1.9M | $-7.5M | $-1.6M | $-1.3M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | $-1.2M | $-2.3M | $-3.1M | $-2.1M | $-1.9M | $-7.5M | $-1.6M | $-1.3M |
| Net Margin | -291.1% | -2,397.4% | -9,648.6% | — | — | — | — | — |
| EPS (Basic) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.01 | $0.00 | $0.00 |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.01 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 816.8M | 781.0M | 773.6M | 708.1M | 674.0M | 635.2M | 585.4M | — |
| Shares Outstanding (Diluted) | 816.8M | 781.0M | 773.6M | 708.1M | 674.0M | 635.2M | 585.4M | — |
| Dividends Per Share | — | — | — | — | — | — | — | — |